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1. Introduction 
 
Living organisms have developed complex metabolic networks in order to generate the 
biomolecules and energy required for survival and proliferation. These metabolic networks 
consist of a huge numbers of different metabolic enzymes catalyzing distinct chemical reactions. 
In principle, these reactions can be divided into two groups: anabolic reactions, which are 
endergonic (energy absorbing) processes to synthesize macromolecules, and catabolic reactions, 
which breakdown macromolecular substrates in order to generate energy and thereby also 
generate new products/substrates (Figure 1.1). Both networks consist of a huge variety of 
different enzymatic reactions forming characteristic intermediates, which can serve as new 
substrates for further catabolic or anabolic reactions. According to the cell’s needs, the pathways 
for building up and breaking down cellular components can be turned on and off or sped 
up/slowed down. Therefore it is crucial for the cell to develop regulatory mechanisms to monitor 
and balance the different metabolic pathways.  
 
 
Figure 1.1. Schematic overview on cell metabolism (Nature Education 2010) 
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1.2. Cell catabolism – delivering the energy for life 
 
Living systems rely on a constant supply of free energy to maintain 3 major processes, 
mechanical work like cellular movements or muscle contractions, active transport of molecules 
and ions, and synthesis of macromolecules and other biomolecules. The major energy carriers 
providing the required vigor are nucleotide triphosphates (NTPs), of which adenosine 
triphosphate (ATP) is perhaps the most famous. ATP consists of an adenosine and three 
phosphate groups containing two energy rich phosphoanhydride bonds. The free energy resulting 
from the hydrolysis of these bonds (Figure 1.2.) drives thermodynamic unfavorably enzymatic 
reactions. 
 
Figure 1.2. ATP structure and free energy resulting from hydrolysis of phosphoanhydride bonds 
 
Since ATP is an energy carrier, which serves not as an energy store, there is a very high turnover 
of ATP, ADP, and AMP molecules. Cells are able to sense their current energy status by 
determining the ration between ATP and AMP through highly specific cellular energy sensors 
like adenosine monophosphate-activated protein kinase (AMPK) and subsequently modulate 
metabolic pathways to produce or consume ATP (Hardie et al. 1999). 
Another role of ATP is in signal transduction pathways. Kinases use ATP as a phosphate donor 
to phosphorylate proteins, which commonly leads to protein activation driving signal 
transduction processes. Finally ATP can also be used as donor for AMP during DNA-synthesis. 
There are several ATP analogs like guanosine triphosphate (GTP), uridine triphosphate (UTP) 
and cytidine triphosphate (CTP), which are mainly used for DNA/RNA synthesis, but there are 
also metabolic processes which specifically utilize these triphosphates, e.g. glycogen syntheses 
(UTP), pyrimidine biosynthesis (CTP), and microtubule organization (GTP). 
The main energy source for living cells is provided by the consumption of glucose. Glucose is 
metabolized through glycolysis and the subsequent tricarboxylic acid (TCA) cycle. During 
glycolysis a series of ten enzymatic reactions convert glucose to pyruvate (Figure 1.3.).  
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Figure 1.3. Overview glycolytic pathway from glucose to pyruvate and subsequent fermentation reactions to lactate or 
ethanol 
 
The first key reaction is the phosphorylation of glucose by hexokinase thereby forming glucose-
6-phosphate. This is followed by an isomerization by glucose phosphate-isomerase to fructose-6-
phosphate. Further phosphorylation of fructose-6-phosphate by phosphofructokinase, 
consuming one ATP, leads to the formation of fructose-1,6-bisphosphate. The reaction of 
phosphofructokinase is a key step in regulating this process. Subsequent action of the enzyme 
aldolase leads to a cleavage of fructose-1,6-bisphosphate into dihydroxyacetone-phosphate and 
glyceraldehyde-3-phosphate. Since these two metabolites are isomers, triose phosphate-isomerase 
can convert dihydroxyacetone-phosphate to glyceraldehyde-3-phosphate. Two molecules of 
glyceraldehyde-3-phosphate are then metabolized to 1,3–bisphosphoglycerate by the enzyme 
glyceraldehyde-3-phosphate dehydrogenase, which reduces nicotinamide adenine dinucleotide 
(NAD+) to NADH.. This is followed by the conversion of 1,3–bisphosphoglycerate to 3-
phosphoglycerate catalyzed by phosphoglycerate kinase, which leads to the generation of ATP. 
The subsequent reactions from 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate-
INTRODUCTION          8 
mutase, followed by enolase which generates phosphoenolpyruvate leads to the last important 
reaction of glycolysis the formation of pyruvate by pyruvate kinase, which again leads to 
production of ATP. In summary, the consumption of one molecule of glucose and one NAD+ by 
the glycolytic pathway leads to the net production of 2 molecules of pyruvate, 2 ATP, and one 
NADH.  
Pyruvate can be further utilized for ATP generation by entering the tricarboxylic acid (TCA) 
cycle. Although this marks the main metabolic pathway in energy metabolism, two other 
pathways exist for metabolizing pyruvate. Under hypoxic conditions, yeast (and other 
microorganisms) can convert pyruvate to ethanol (Figure 1.3.). The second possibility is the 
generation of lactate through the activity of lactate dehydrogenase (Figure 1.3.). While this activity 
is also found in microorganisms, the best example is muscle cells after intensive mechanical work. 
Both reactions occur in the absence of sufficient oxygen and do not produce ATP, however they 
are needed for the regeneration of NADH (produced during glycolysis) to NAD+ in order to 
maintain a high rate of glycolysis. Since all reactions of glycolysis are carried out in the cell 
cytoplasm, the reaction from pyruvate to acetyl-coenzyme A by the pyruvate dehydrogenase is a 
key step for entering the mitochondria, where the reactions of the TCA cycle occur (Figure 1.4.). 
Upon entering the mitochondria, acetyl-coenzyme A (acetyl coA) enters a condensing reaction 
with oxaloacetate to forms citrate, catalyzed by citrate synthase. Afterwards, citrate isomerizes to 
isocitrate. This is followed by oxidative decarboxylation by isocitrate dehydrogenase leading to 
the formation of α-ketoglutarate and the oxidation of NAD+ to NADH. A second oxidative 
decarboxylation is characterized by the formation of succinyl coA and again the formation of 
NADH. Succinyl coA is than further metabolized to succinate, which leads to the formation of 
GTP. In the following 3 reactions, succinate is then converted to fumarate and subsequently 
malate, which in turn regenerates oxaloacetate enabling it to bind new acetyl-coA again. During 
the TCA cycle, the generation of 3 molecules of oxidized NADH per one molecule of acetyl-coA 
is essential for the following energy producing steps. 
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Figure 1.4. schematic overview over TCA-cycle reactions 
 
Through the electron transport chain during the oxidative phosphorylation the reduction of 
NADH to NAD+ leads to a formation of proton gradient at the mitochondrial membrane, which 
drives ATP synthesis by the enzyme ATP-synthase. In total, during the TCA-cycle and 
subsequent oxidative phosphorylation, 28 molecules of ATP are generated, making this the main 
energy producing process in the cell. 
 
1.3 Metabolism in cancer 
 
The pathways of glycolysis and the TCA-cycle are highly conserved throughout living organisms. 
Although the energy delivered to maintain cellular homeostasis is predominantly produced by the 
TCA-cycle, the process of completely breaking down glucose is rather slow. In proliferating and 
rapidly growing cells the demand for energy and nutrients is high, which requires changes in the 
metabolic signature. One example of abnormal cell proliferation is cancer. Cancer metabolism 
has been extensively studied in the last decades beginning with the fundamental observation 
made by Otto Warburg in the 1920s. He showed that in the presence of oxygen, cancer cells 
favored the conversion of glucose via glycolysis and subsequent reaction from pyruvate to lactate 
instead of further metabolizing it through the TCA-cycle and oxidative phosphorylation 
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(WARBURG 1956). This feature, termed the “Warburg effect”, has been described for many 
types of tumors and is now considered a hallmark of cancer. One explanation for this altered 
metabolism is the selective advantage for survival and proliferation in the tumor 
microenvironment. During tumor progression, the oxygen levels within the tumor 
microenvironment vary spatially and temporally selecting for cells that constitutively upregulate 
glycolysis. This is characterized by the increased expression of glycolytic enzymes, glucose 
transporters, and inhibitors of mitochondrial metabolism (Yamamoto et al. 1990; Mathupala et al. 
1997; Rivenzon-Segal et al. 2003). One mechanism to upregulate glycolysis is the stabilization of 
hypoxia-inducible transcription factor (HIF). HIF initiates a transcriptional program providing 
the basics of upregulated glycolysis under hypoxic stress (Cramer et al. 2003). Since the 
stabilization of HIF is coupled to oxygen levels, it is not the only factor responsible for altered 
metabolism. Also the increased expression and/or stabilization of certain oncogenes have been 
described to play a role in the upregulation of glycolysis. Mutations in the proto-oncogene Ras 
(Flotho et al. 1999; Stirewalt et al. 2001), AKT (Zeng et al. 2006) and PI3kinase (Jücker et al. 
2002) which play an important role in insulin signaling as well as the transcription factor Myc 
(Dang et al. 2009; Gao et al. 2009) have all been shown to be responsible for the expression of 
metabolism related genes.  
Often mutations of regulatory proteins lead to tumor progression, characterized by altered 
metabolism. These characteristic metabolic signatures are not unique to tumor cells, but in fact 
are features of highly proliferating cells found in higher organism. One example of such cells are 
T lymphocytes in the immune system. Upon recognition of their antigen, a small number of cells 
expand within hours to form an effector population. This strong proliferation shares similarities 
in its metabolic profile to cancer cells. In addition, when T lymphocytes are recruited to a site of 
infection to fight pathogens or to restrict tumor progression they encounter a similar 
microenvironment like cancer cells. Thus, by adjusting their metabolic features T lymphocytes 
can maintain their protective function within the immune system. 
 
1.4. The immune system 
 
The main task for the immune system is to prevent and/or eliminate pathogens causing a wide 
variety of diseases. Therefore the innate and the adaptive immune system are the pillars of the 
immune response. If pathogens overcome the physical barriers and enter the organism, the innate 
immune system provides a fast, non-specific response. If the mechanisms of the innate immune 
response fail to clear a pathogen, then an adaptive immune response develops. Adaptive 
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immunity acts by specific recognition and selective elimination of the target. Adaptive immunity 
is triggered when foreign antigens enter into secondary lymphoid organs by diffusion or are 
presented by specific antigen presenting cells (APCs). There are two types of lymphocytes 
characteristic for adaptive immune response. B lymphocytes regulate humoral immunity by 
secreting immunoglobulins, which eliminate pathogens by neutralization, agglutination, 
phagocytosis, and/or complement activation. B lymphocytes development in the bone marrow 
from pluripotent stem cells via a series of different progenitor stages which in the end leads to 
the clonal expansion of the mature B cells upon the binding of foreign antigen to the B cell 
receptor (BCR). A second type of lymphocyte, T lymphocytes, is required for cell mediated 
immunity. Upon triggering the specific T cell receptor (TCR), T cells proliferate and differentiate 
into different effector cells. Cytotoxic T cells kill infected or damaged cells, whereas Helper T 
cells coordinate the immune response by secreting specific cytokines. T cells develop in the 
thymus, where they undergo two selection processes. The first process, positive selection, ensures 
that only T cells with receptors that can recognize self-MHC molecules survive. The second 
process, negative selection, eliminates T cells that strongly recognize self-antigens on MHC 
molecules, thereby ensuring that only those cells able to detect foreign peptides are allowed to 
exit the thymus. In addition, there exist populations of regulatory lymphocytes, called native or 
inducible regulatory T cells (nTregs or iTregs), which control the amount of differentiated cells 
and inhibit further proliferation once the pathogen is cleared. A small amount of the 
differentiated cells remain as long lived memory cells to ensure protection should the same 
pathogen be encountered again. 
 
1.4.1. T cell development and activation 
 
T cells play a central role in the immune system and are important for cell mediated immunity. 
Initiation of T cell receptor signaling is a critical step for the activation of T cells and therefore 
requires tight control. The T cell receptor is formed during thymocyte development. These 
selection processes ensure that only receptors with a weak affinity for self MHC exit into the 
periphery. Naïve T cells can be distinguished by their expression of the surface molecules CD4 
and CD8. CD4 T cells, also called helper T cells are restricted to MHC-class II recognition 
whereas cytotoxic CD8 T cells only recognize MHC-class I molecules. They are constantly 
recirculating between peripheral lymphoid organs and the bloodstream until they encounter their 
specific antigen. These antigens are expressed on antigen presenting cells (APCs) like B cells, 
dendritic cells, and macrophages as peptide-MHC class I or II complexes. Upon recognition of 
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antigen by the T cell receptor (TCR) an adaptive immune response is initiated (von Andrian et al. 
2000; Mescher et al. 2006). The TCR consists of 2 transmembrane proteins termed the α and β 
chain. The extracellular domains of these two chains contain variable regions, which are capable 
of binding the peptide-MHC complex. Since the variable chains are formed during thymocyte 
development by somatic recombination every T cell harbors a different TCR with unique 
specificity. However, the α and β chains lack cytoplasmic domains and thus are not able to 
transmit signals into the cell. Signals via the TCR are transmitted via the noncovalently associated 
CD3 subunits, namely one heterodimer consisting of γ and ε and another of δ and ε chains, as 
well as a homodimer of ζ chains. These subunits possess intracellular tails containing specific 
signaling motifs called immunoreceptor tyrosine-based activation motifs (ITAMs). Upon 
triggering of the TCR these ITAMs become phosphorylated by members of the Src family of 
protein tyrosine kinases, namely LCK and Fyn. 
Phosphorylated ITAMs provide docking sites for the tandem SH2 domains of the Syk family 
kinase ZAP70, which is thereby recruited to the plasma membrane and itself becomes activated 
via phosphorylation by Lck (Chan et al. 1992; Chan et al. 1995). One important target of ZAP70 
is the transmembrane adaptor called the linker for activation of T cells (LAT). Phosphorylated 
LAT serves as a scaffold to recruit further downstream molecules, which activate distinct 
signaling pathways leading to the activation of transcription factors, such as NFAT, NF-B and 
AP-1. These transcription factors are required for initiating cytokine production, T cell 
proliferation, and differentiation.  
Translocation of the transcription factor NFAT into the nucleus is Ca2+ dependent. Upon 
recruitment and activation of PLCγ1 in the LAT complex results in hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) producing two second messengers diacylglycerol 
(DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 binds to the IP3 receptor on the endoplasmic 
reticulum inducing a transient increase in free intracellular Ca2+, which binds to calmodulin which 
in turn activates calcineurin, a Ca2+/calmodulin-dependent protein phosphatase. Activated 
calcineurin dephosphorylates the transcription factor NFAT, thereby allowing its translocation to 
the nucleus (Garcia-Cozar et al. 1998).  
The transcription factor AP-1, a heterodimer consisting of the transcription factors Fos and Jun, 
is activated via the MAP kinase pathways. The transcription factor Fos is activated by the Ras-
Raf-MEK-ERK pathway which can be triggered by the recruitment of Grb2/SoS to LAT or via 
the activation of RasGRP by DAG (Genot et al. 2000; Jones et al. 2002). Furthermore upon TCR 
triggering SLP76 is recruited to phosphorylated LAT and leads to phosphorylation of Vav1, 
which in a series of events leads to the activation of Jnk. Phosphorylated JNK is then required 
for activation of Jun (Saez-Rodriguez et al. 2007).  
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Activation of the transcription factor NF-B is dependent on the activation of protein kinase C 
(PKC) via DAG. This leads to the formation of the Carma1-BCL10-MALT1 (CBM) complex, 
which in turn activates the IKK complex leading to the degradation of inhibitory protein IBα. 
Removal of this inhibitor allows the active transcription factor NF-B to translocate into the 
nucleus (Ruefli-Brasse et al. 2003; Egawa et al. 2003). 
A variety of stimuli, including soluble or immobilized antibodies (Abs) that recognize the T cell 
receptor (TCR), peptide-loaded APCs, or MHC-I tetramers carrying high- or low-affinity 
peptides, have been used to study T cell activation. It was previously shown that different stimuli 
used to activate the TCR can lead to either a strong/transient activation of signaling molecules or 
to weak/sustained signal. The former lead to apoptosis, while the latter induces proliferation 
(Wang et al. 2008). Interesting this was true for both thymocytes (Daniels et al. 2006) and 
peripheral T cells (Wang et al. 2008). However, it is poorly understood how triggering of the 
same receptor with ligands of different affinity can induce these different outcomes. Though, it is 
known that thymocytes which cannot fulfill their energy demands undergo apoptosis (Daniels et 
al. 2006). Therefore we hypothesized that changes in the metabolic profiles of activated T cells 
might contribute to cell fate specification. 
 
1.5. Metabolic signatures of the immune system 
 
A functional immune response requires rapid cell growth, proliferation, and the production of 
effector proteins. In the presence of its specific antigen, T lymphocytes must rapidly shift from a 
resting state to an activated one in order to accomplish these tasks. The activation of T cells is 
accompanied by a huge demand for ATP; the major energy source in cell metabolism. The main 
pathways for generating ATP are glycolysis and the TCA cycle followed by oxidative 
phosphorylation. Resting T cells require relatively low amounts of energy for housekeeping 
functions, i.e. homeostasis. Most of this energy is produced by oxidative phosphorylation 
(OXPHOS) through the degradation of glucose, fatty acids, and glutamine (Roos,Loos 1973). 
Upon activation, cellular programs direct T cells towards proliferation, differentiation, and 
cytokine production. Especially during rapid proliferation where T cells expand exponentially 
they must double their intracellular content, i.e. lipids, proteins and nucleic acids. The subsequent 
increasing need for energy and metabolic precursors was shown to be accomplished by a strong 
upregulation of glycolysis (Greiner et al. 1994). Although the generation of ATP by glycolysis is 
inefficient when compared to OXPHOS, upregulating glycolysis has the advantage of being a fast 
process and was shown to protect cells from apoptosis (Perl et al. 2002). Since upregulating 
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glycolysis without a corresponding increase in OXPHOS would lead to an accumulation of the 
end product pyruvate, it was shown that the excess pyruvate generated is converted to lactate by 
lactate dehydrogenase (Brand et al. 2005). This step is essential to regenerate the reducing 
equivalent NADH, which is needed to maintain the high glycolytic turnover. It was shown for 
muscle cells that high intracellular concentrations of lactate are secreted by an active cotransport 
via monocarboxylic transporters together with an H+ which in turn leads to extracellular 
acidification. To prevent lactic acidosis the extracellular lactate is then transported via the 
bloodstream to the liver where during gluconeogenesis lactate is metabolized back to glucose 
(Juel 1997). 
These observations lead to the conclusion that glucose is the major energy source of activated 
lymphocytes. This was also confirmed by showing that removing glucose in activated T cells 
leads to an inhibition of T cell proliferation and cytokine production (Greiner et al. 1994; 
MacDonald et al. 1979). In addition, also other metabolic pathways have been shown to play a 
role in T cell metabolism, e.g. increased glutamine consumption was shown to be essential for T 
cell function (MacDonald et al. 1979; Brand et al. 1984). The degradation of glutamine is an 
energy-producing pathway by entering the TCA cycle, which in the end leads to the conversion 
from malate to pyruvate. This pyruvate together with an upregulated glycolysis can foster the 
generation of lactate. Glutamine is also needed to refill intermediates of the TCA cycle, which are 
also used for biosynthetic processes that are essential for maintaining T cell proliferation, i.e. 
providing a nitrogen source for non-essential amino acids and nucleotides. Beside the generation 
of ATP, T cells also require NADPH to support lipid and nucleotide biosynthesis. NADPH is 
generated in two different processes, the pentose-phosphate-pathway dependent on glucose-6-
phosphate and the last step of glutamine degradation – the conversion from malate to pyruvate. 
This suggests that glucose and glutamine are the major nutrients required for T cell proliferation. 
 
1.5.1. Protein Kinase B/AKT 
 
The most prominent pathway responsible for upregulating glycolysis is the PI3K/AKT pathway. 
In T cells, coligation of the TCR and the costimulatory molecule CD28 leads to direct 
phosphorylation of phosphatidylinositol-4,5-bisphosphate (PIP2) by phosphoinositide 3-kinase 
(PI3K), which in turn leads to increased levels of phosphatidylinositol-3,4,5-trisphosphate (PIP3) 
within the membrane. AKT translocates to the plasma membrane since it binds to PIP3 via its 
PH-domain, where it can be phosphorylated by PDK1 on Thr308. For full activation, AKT 
requires an additional phosphorylation on Ser473 by mTOR complex 2. It was shown for T cells 
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that sustained activation of AKT upregulates the glucose transporter 1 (GLUT1) and increases 
the activity of the rate-limiting glycolytic enzyme hexokinase (Frauwirth et al. 2004). Together 
with the observations that AKT regulates the activity of hexokinase and phosphofructokinase the 
two rate limiting enzymes of the glycolysis, it can be hypothesized that AKT is responsible for 
regulating enzymes of glycolysis and lactate production, which leads to an increased glycolytic 
rate. The observations on the activating role of AKT were mostly performed in primary human T 
cells stimulated with CD3 and CD28, which fully activate AKT. This led to upregulation of 
GLUT1 and glucose uptake, which could be inhibited by addition of CTLA4 (Frauwirth et al. 
2004; Parry et al. 2005).  
1.5.2. Mammalian Target of Rapamycin - mTOR 
 
In T cells, mTOR exists as one gene, but forms two distinct protein complexes: mTOR complex 
(mTORC) 1 and mTORC2, which differ in their inputs and substrates (Hara et al. 2002; Kim et 
al. 2002; Sarbassov et al. 2004). The mTORC1 complex consists of the regulatory-associated 
protein of mTOR (Raptor), mLST8, PRAS40, and DEPTOR. The proteins mLST8 and 
DEPTOR are also found in the mTORC2 complex, with the addition of RICTOR, mSIN1 
proteins, and PROTOR (Kim et al. 2002). Upstream of the mTORC1 complex is the small 
activating GTPase Ras homolog enriched in brain (Rheb), the function of which is regulated by 
the GAP activity of tuberous sclerosis complex 1 (TSC-1) and TSC-2 (Zhang et al. 2003). 
Phosphorylation of TSC-1/2 by AKT leads to inhibition of the GAP activity and subsequent 
inactivation of Rheb (Tee et al. 2003).  
Additionally, AKT-mediated inhibition of PRAS40 has been shown the promote mTORC1 
activity independently of TSC-1/2 (Wang et al. 2007). mTORC1 is known to play a critical role in 
regulating mRNA translation, glucose and lipid metabolism, mitochondrial biosynthesis, and 
autophagy (Düvel et al. 2010). Recent studies have shown that mTORC2 is strongly and 
specifically activated following association with ribosomes, whereas its kinase activity is inhibited 
by endoplasmic reticulum stress and the glycogen synthetase kinase-3b (GSK-3b) (Chen et al. 
2011). Downstream targets of mTORC2 include AKT, serum and glucocorticoid-inducible 
kinase 1, and protein kinase C (Guertin et al. 2006). Therefore it is known that AKT acts 
upstream as a regulator of mTORC1 activity, which is dependent on the phosphorylation of 
AKTT308 by the PI3K/PDK1 pathway. Additionally AKT is also a downstream target of 
mTORC2, which phosphorylates AKTS473 (Sarbassov et al. 2005; Guertin et al. 2006). 
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1.5.3. AMPK 
 
Another important regulator of cellular metabolism is adenosine-monophosphate kinase 
(AMPK), which promotes ATP conservation and production through the activation of glycolysis, 
fatty acid oxidation, and the inhibition of ATP-consuming pathways, such as protein synthesis, 
fatty acid synthesis, gluconeogenesis, and glycogen synthesis. AMPK can be activated by an 
increase in the AMP:ATP ratio followed by phosphorylation through LKB1 (a serine/threonine 
kinase)(Hardie et al. 1999; Woods et al. 2003; Cao et al. 2010) . In addition it has been shown that 
Ca2+-calmodulin-dependent kinase kinase 2 (CAMKK2) can activate AMPK independent of 
AMP levels (Hurley et al. 2005; Tamás et al. 2006). This suggests that LKB1/AMPK antagonize 
the PI3K/AKT/mTOR pathway, which promotes anabolism. This could be confirmed by the 
observations that AMPK activation was shown to be transient upon T cell stimulation (Tamás et 
al. 2006). Additionally, AMPK was shown to be required for memory T cell differentiation. 
Addition of the drug metformin caused an sustained activation of AMPK and subsequently led to 
increased numbers of memory T cells (Rolf et al. 2013). Recent studies showing that 
LKB1/AMPK influences assymetric cell division in D. melanogaster (Mirouse et al. 2007; Lee et al. 
2007), suggest that there could be a role for AMPK in the assymetric division T cells. Since 
sustained activation of AKT is needed for effector T cell differentiation and AMPK activation 
appears to be only transient under these conditions, one could hypothesize that the contact of a 
T cell  to an APC could also lead to a polarized distribution of metabolites.  
1.5.4. Transcription factors 
 
Recently several studies have further analyzed the connection between the major metabolic 
regulators and metabolism. It was investigated whether transcription factors like Hif1α  and MYC 
play an important role in expression of metabolic enzymes. Hif1α is a transcription factor that 
regulates the expression of genes that encode for glycolytic enzymes as well as downregulates 
mitochondrial oxygen consumption by blocking the entrance of pyruvate into the TCA cycle 
(Firth et al. 1994; Semenza et al. 1996). Hif1α is constitutely active, but under normoxic 
conditions, it is rapidly degraded. Under low oxygen conditions the degradation of Hif1α is 
inhibited and it translocates to the nucleus where it upregulates glycolytic genes and drives the 
cell towards aerobic glycolysis. Another factor investigated was the proto-oncogenic transcription 
factor Myc, which was shown to be induced upon T cell stimulation (Douglas et al. 2001). The 
deletion of Myc lead to an impaired upregulation of glycolysis and glutaminolysis, and a 
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decreased activation of targets downstream of mTOR. These observations led to the conclusion 
that Myc is probably the major transcription factor regulating T cell metabolism upon activation.  
 
1.6. Aim of the project 
 
It was previously shown that triggering of the T cell receptor with stimuli of different affinities 
lead to different outcomes. Activation of CD8 T cell with soluble CD3 and CD8 antibodies lead 
to the strong phosphorylation of downstream molecules like ZAP70, LAT, and ERK (Wang et al. 
2008). However this activation was transient and the T cells failed to induce proliferation, but 
rather undergo apoptosis within 24h. On the contrary, stimulation with MHC-I tetramers 
presenting the OVA peptide lead to a weak, but sustained activation of signaling molecules. Here, 
the T cells were able to survive and proliferate.  
Based upon these results, I generated the hypothesis that different stimuli could induce different 
metabolic signatures, which in turn could explain the different phenotypes/functional outcomes. 
To test this hypothesis, I analyzed and compared specific metabolic features upon TCR 
triggering. 
A second goal was to further analyze the metabolic parameters upon TCR triggering to provide a 
more detailed overview of how metabolism is regulated in T cells. Therefore, I analyzed the early 
changes in metabolism which enable T cells to switch from a resting state to an activated and 
proliferative phenotype. Furthermore I assessed regulatory parameters to elucidate the role of 
signaling proteins like AKT, mTOR and CTLA4 in upregulation of glucose metabolism and 
subsequent down modulation of these energy demanding processes. 
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2. Materials and Methods 
 
2.1. Antibodies used in this study 
 
Antibody Species and clone Application Source 
actin  mouse monoclonal 
IgG1(AC-15) 
WB - 1:10,000 Sigma-Aldrich 
anti-mouse-HRP goat WB - 1:10,000 Dianova 
 
anti-rabbit-HRP  goat WB - 1:10,000 Dianova 
 
AMPKα mouse monoclonal 
(F6) 
WB - 1:1000 cell signaling 
technologies 
AMPK –pT172 rabbit polyclonal WB - 1:1000 cell signaling 
technologies 
CTLA-4-PE (CD152) mouse monoclonal 
(UC10-4F10-11) 
FACS – 1:100 BD 
CD3ε-biotin mouse monoclonal 
(145-2C11) 
stimulation BD 
CD8α mouse monoclonal 
(53-67) 
stimulation BD 
Erk1/2 –  
p Thr202/pTyr204 
rabbit monoclonal 
(D13.14.4E) 
WB – 1:1000 cell signaling 
technologies 
GLUT1 rabbit monoclonal 
(EPR3915) 
FACS - 1:100 Epitomics 
Hexokinase rabbit monoclonal 
(C35C4) 
WB - 1:1000 cell signaling 
technologies 
HIF1α-hydroxy- P564 rabbit monoclonal 
(D43B5) 
WB - 1:1000 cell signaling 
technologies 
JNK 
pThr183/pTyr185 
rabbit polyclonal WB- 1:1000 cell signaling 
technologies 
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LDHA rabbit polyclonal WB - 1:1000 cell signaling 
technologies 
Phosphofructokinase 
(PFK1) 
mouse monoclonal 
(E9) 
WB - 1:1000 santa cruz 
biotechnologies 
p70-S6K – pT389 mouse monoclonal 
(1A5) 
WB - 1:1000 cell signaling 
technologies 
Stat5-pY694 rabbit monoclonal 
(C11C5) 
WB - 1:1000 cell signaling 
technologies 
Stat5-pY694 mouse monoclonal 
(C47) 
FACS – 1:100 BD  
 
2.2. General reagents for cell culture 
 
RPMI 1640 medium with NaHCO3 and stable glutamine   Biochrom AG 
PBS without Ca2+Mg2+       Biochrom AG 
FCS          PAN Biotech GmbH 
CiproBay 200         Bayer 
Trypan blue         Sigma 
 
2.3. Inhibitors used in this study 
Inhibitor concentration used Source 
AKT V 1µM Calbiochem 
AKT VIII/AKTi 2µM Calbiochem 
AKT XII 5µM Calbiochem 
Oxamate 50mM Sigma Aldrich 
Rapamycin 2mM Sigma Aldrich 
Rotenone 100nM Sigma Aldrich 
 
All inhibitors were tested for induction of necrosis/apoptosis and specific function for various 
concentrations. The concentrations depicted are the ones used in the subsequent experiments. 
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2.4 Analysis of human T cells 
 
2.4.1. Isolation and purification of human T cells 
 
Reagents and instruments: 
Ficoll Biochrom AG 
Heparin Biochrom AG 
Pan T cell isolation kit II Miltenyi Biotec 
AutoMACS Miltenyi Biotec 
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient centrifugation of 
heparinized blood collected from healthy volunteers. A ring containing PBMCs formed during 
the gradient centrifugation. PBMCs were carefully aspirated and washed 3x with RPMI 1640 
medium. The cells were rested in RPMI 1640 medium supplemented with 10% FCS for 2 hours 
in an incubator. T cells were further purified by non-T cell depletion on the AutoMACS machine 
using the Pan T cell isolation kit II. T cell populations of greater than 95% purity were obtained, 
as determined by flow cytometry analysis. 
2.4.2. Stimulation of human T cells 
 
For microbead stimulation, SuperAvidin™-coated polystyrene microspheres (Ø ~ 10 μm, Bangs 
Laboratories) were coated with biotinylated CD3 alone or in combination with CD28 and CD4 
mAbs as indicated (10 μg/ml each) for 30 min at 37 °C in PBS. Antibody-coated microbeads 
were washed twice with PBS, resuspended in RPMI 1640 and incubated with T cells in a 1:1 ratio. 
2.5. Animal experimentation 
2.5.1. Mice condition and handling 
 
Mice were kept in the central animal facility at the Otto-von-Guericke-University of Magdeburg 
and maintained in pathogen-free conditions. All experiments involving mice were performed 
according to the guidelines of the State of Sachsen-Anhalt,Germany. 
  
MATERIALS AND METHODS        21 
2.5.2 Genomic DNA isolation from mouse tails 
 
Genomic DNA was purified from a 1 cm piece of mouse tail, provided from the animal facility 
and placed into a 1.5 ml eppendorf tube. The mouse tail was predigested by incubation with 600 
μl Tail lysis buffer and 6 μl proteinase K solution at 56°C for 3-5 h under constant shaking. After 
a centrifugation for 10 min at 10000 rpm the supernatant was added to a new tube containing 
600µl isopropanol. Next the sample was centrifuged again for 10min at 12000 rpm and 
subsequently washed with 600 µl ice-cold ethanol, centrifuged again for 5 min at 12000 rpm and 
dried on a paper towel for 30min. The dried DNA was than resuspended in 150µl water and 
stored at 4°C. 
2.5.3. Genotyping of OT-I-transgenic mice strain by PCR  
 
Genotyping of the OT-I transgenic mice was performed according to the PCR protocol 
established by Jackson Laboratories. 
Primers used for genotyping (Metabion): 
Primer 1 (internal control F): 5’- CAA ATG TTG CTT GTC TGG TG -3’ 
Primer 2 (internal control R): 5’- GTC AGT CGA GTG CAC AGT TT-3’ 
Primer 3 (OT1-TCR F): 5’- AAG GTG GAG AGA GAC AAA GGA TTC-3’ 
Primer 4 (OT1-TCR R): 5’- TTG AGA GCT GTC TCC-3’ 
The following reaction mix was pipetted into the PCR tube according to the manufacturer’s 
protocol: 
 
PCR reaction mix PCR program 
Primer 1 0.25 μl (1 μM) Hot start 94°C, 3 min 
Primer 2 0.25 μl (1 μM) Denaturation 94°C, 30 sec 
Primer 3 0.125 μl (0.5 μM) Hybridization 52°C, 30 sec 38 cycles 
Primer 4 0.125 μl (0.5 μM) Elongation 72°C, 30 sec 
Taq polymerase 0.5 μl (2.5 U) Final elongation 72°C, 2 min 
5 x enhancing buffer 5 μl  
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10 x reaction buffer 2.5 μl  
dNTP (mix) 0.25 μl (200 μM)  
dH2O up to 23.5 μl  
To each reaction 1.5 μl DNA was added  
 
2.5.4. Gel electrophoresis of nucleic acids 
 
1 x TAE buffer:    10 mM Tris 
0.1142% acetic acid 
1 mM EDTA pH 8.0 
Agarose gel 2%:    2 g agarose 
100 ml 1 x TAE buffer 
10 μl ethidium bromide (10 mg/ml) 
6 x loading buffer:    30% glycerol 
20 mM Tris (pH 7.6) 
2 mM EDTA 
0.02% bromphenolblue 
0.02% xylenxylanol 
Marker:     GeneRuler 50 bp DNA Ladder 
The reaction was analyzed by mixing the PCR products with 6 x loading buffer and loaded on a 
2% agarose gel supplemented with ethidium bromide. Electrophoresis was carried out with a Bio-
Rad Mini DNA system in TAE-buffer at 100 V for 30 min. DNA fragments were visualized by 
UV light observing a band at ~200bp referring to the internal TCR control and at ~350bp 
referring to the transgene. 
  
MATERIALS AND METHODS        23 
2.5.5. Purification of CD8+ OT-I T cells from mouse spleen 
 
Pan T cell isolation kit mouse Miltenyi Biotec 
AutoMACS Miltenyi Biotec 
 
Mice were sacrificed and the spleens were removed. To disrupt the organs and to release the 
cells, the spleen was mashed through a 40 μm diameter pore-size strainer with a syringe plunger 
at room temperature. Cells were collected in a 15 ml tube and washed by adding ice-cold PBS to 
a final volume of 15 ml and centrifuged for 10 min, 370 g, at 4°C. The pellet was resuspended in 
10 ml ice-cold PBS and the cell number was determined. 
Since OT-I TCR tg mice contain only CD8+ T cells, a Pan T cell isolation kit was used for 
purification. The single cell suspension was centrifuged at 370 g for 10 min. The cell pellet was 
resuspended in ice-cold PBS at a concentration of 10 x 106 cells/45 μl. Staining was performed 
with 5 μl Biotin-Antibody Cocktail (cocktail of biotin-conjugated monoclonal antibodies against 
CD11b (Mac-1), CD45R (B220), DX5 and Ter-119) and incubated for 10 min on ice. 
Subsequently, the cell suspension was mixed together with 40 μl of ice-cold PBS per 10 x 106 cells 
and 10 μl of anti-Biotin MicroBeads. The mixture was incubated for 15min on ice. Afterwards 
the cells were washed once with 10 ml of ice-cold PBS and centrifuged at 370 g for 10 min. The 
supernatant was removed and the cell pellet was resuspended in PBS at the concentration of 1 x 
108cells/ml. The magnetic separation was performed by using the Auto-MACS separator. The 
purity of isolated cells was determined by flow cytometry. 
Since CTLA4-/- mice provided by the group of Prof. Brunner-Weinzierl were also crossed onto 
the OT-I transgenic background, the purification procedure was the same as described above. 
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2.5.6. OT-I T cell stimulation in vitro 
2.5.6.1 Stimulation with OT-I tetramers 
 
Mouse medium:     RPMI-1640 
10% FBS 
1% antibiotics (penicillin and streptomycin) 
1.75 μl 2-mercaptoethanol (in 500 ml RPMI) 
Prior to stimulation of T cells with OT-I tetramers, 0.75 μg Strep-Tactin was incubated with 
recombinant monomeric biotinylated-MHC-I (1 μg) in a final volume of 50 μl with PBS or 
mouse medium at 4°C for 45 min according to the manufacturer’s instructions. Recombinant 
monomeric biotinylated H-2Kb molecules presenting the ovalbumin SIINFEKL peptide 
(OVA) or presenting the SIIQFEHL peptide (Q4H7) for the OT-I TCR were used in this 
study. 2 x 10
6
 purified T cells were resuspended in 50 μl PBS or mouse medium. 
Subsequently, the cell solution was mixed with the OT-I tetramers (pMHC-strep-tactin) at 
37°C for the indicated time points. Stimulation was stopped by adding 1 ml ice-cold PBS. The 
procedure was continued according to the specific purpose. 
2.5.6.2. stimulation with CD3/CD8 mAbs 
 
2 x 10
6
 purified T cells were resuspended in 100 μl of PBS or mouse medium. Before 
stimulation, the cells were pre-incubated with biotinylated CD3ε mAb and biotinylated CD8 
mAb (10 μg/ml) at 37°C for 1 min. Stimulation started when cells were cross-linked with 50 
μg/ml streptavidin. 1 ml of ice-cold PBS was added to stop the reaction. The procedure was 
continued according to the specific purpose. 
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2.6. Surface staining and FACS (Fluorescence Activated Cell Sorting) analysis 
2.6.1. Extracellular staining 
 
1 x 10
6
 cells were centrifuged for 5 min, 400 g, at 4°C. The pellet was resuspended in 100 μl 
of the indicated antibody solution. After 30 min of incubation in the dark at 4°C, cells were 
washed with PBS. The cell pellet was resuspended in 300 μl PBS and measured by the FACS 
Diva machine. Data were analyzed using the FlowJo software. 
2.6.2. Proliferation assay 
 
CellTrace™ CFSE Cell Proliferation Kit   Life technologies 
 
1 x 106/ml purified OT-I T cells were incubated with 5µM CFSE for 20min at 37°C in the dark. 
After 2 subsequent washing steps with PBS the cells were resuspended in mouse medium. After 
labeling the cells were cultured in mouse medium using U-bottomed 96-well plates at a 
concentration of 1.5 x 104cells/well. Cells were stimulated with OT-I tetramers (1 μg) alone or in 
the presence of the inhibitors oxamate or rotenone for 72 h at 37°C. Cells were then analyzed for 
proliferation by flow cytometry. 
2.6.3. Apoptosis assay 
 
Annexin V–FITC      Biolegend 
Propidium Iodide      Biolegend 
Cell staining buffer      Biolegend 
Cell apoptosis was analyzed by the ability of Annexin V to bind to exposed phosphatidylserine 
residues at the outer leaflet of the plasma membrane in combination with the application of 
Propidium Iodide (PI). Purified T cells were resuspended in mouse medium at the concentration 
of 1 x 106cells/ml in a 48-well cell culture plate. Cells were left untreated or treated with OT-I-
tetramers (1 μg) alone or in presence of the inhibitors oxamate and rotenone at 37°C for 24h, 
respectively. Cells were harvested and washed with PBS. The cell pellet was resuspended in 195 
μl of cell staining buffer. The staining was performed by mixing the cell solution with 5 μl of 
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Annexin V-FITC and incubating for 10 min at RT in the dark. Afterwards 10 μl PI were added. 
Samples were analyzed by flow cytometry within one hour.  
2.6.4. Glucose uptake 
 
Glucose Uptake Cell-Based Assay Kit    Cayman Chemical 
Annexin V-pacific blue     Biolegend 
Propidium Iodide      Biolegend 
OT-I T cells were stimulated for 24h with OT-1 tetramers and then analyzed with glucose uptake 
cell-based assay kit (Cayman Chemical Company). Cells were harvested and starved for 15min in 
PBS at 37C°. Afterwards fluorescent labelled glucose (150µg/ml, 2-NBDG) was added to the 
cells for 15min. After subsequent washing, the cells were additionally stained as described before 
(2.5.2.) with Annexin V and PI to exclude apoptotic cells and analyzed via FACS immediately. 
 
2.7. Metabolic analysis 
 
2.7.1. Extraction of intracellular metabolites 
 
Methanol       Roth 
Chloroform       Roth 
Tricine        Roth 
 
CD8+ T cells were cultured in mouse medium in 48-well plates at a concentration of 4 x 106 
cells/well. Cells were left unstimulated or stimulated with either CD3/CD8 mAbs or OT-I 
tetramers at 37°C. Cells were harvested after 2h, 4h, 6h and 8h. The cells were immediately 
resuspended in 600µl ice cold Methanol/Chloroform (2:1). Afterwards additional 500µL ice cold 
Methanol/Chloroform (2:1) were added to the samples. In a first extraction step 800µL 
Methanol/3,8mM Tricine (9:10) is added and leads to the separation of the aqueous and the 
organic phase. After vigorous vortexing the sample is centrifuged for 5min at 16000g at 0°C. 
Afterwards the aqueous phase is transferred to a new tube. Then again 800µL Methanol/3,8mM 
Tricine (9:10) is added in a second extraction step to the remaining organic phase, incubated for 
5min at 4°C and subseuqently centrifuged for 5min at 16000g at 0°C. After centrifugation the 
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aqueous phase is pooled together with the one from the first extraction step. Afterwards the 
samples are boiled at 90°C for 4 min followed by a 10min centrifugation step at 16000g and 0°C. 
The liquid supernatant is then transferred to a new tube and dried using a SpeedVAC for 24h and 
can be stored at -80°C. Prior the analysis the pellets are resuspended in 600µl bidest H2O 
followed by a centrifugation for 10min at 16000g at 0°C and the supernatant is transferred to a 
new tube and a sample of 120µL was  measured with MS-coupled anion-exchange 
chromatography (Ritter et al. 2008) in cooperation with the group of Prof. Reichl at the Max 
Planck Institute for Dynamics of Complex Technisl Systems, Magdeburg.  
2.7.2. Measurement of intracellular ATP 
 
ATPlite™ Luminescence Assay System   Perkin Elmer 
Luminometer       Berthold 
1 x 10
6
 purified CD8+ T cells were either left untreated or stimulated with CD3/CD8 mAbs or 
OT-I tetramers for 3´,15´,30´,60´, 120´ and 240´. After stopping the stimulation with ice-cold 
PBS the sample were centrifuged for 2min at 6000 rpm 4°C. The pellets were resuspended in 
100µL PBS and 50µL mammalian cell lysis solution added and placed on an orbital shaker with 
700rpm for 5min. Next 50µL substrate solution containing Luciferase and Luciferin was added to 
the samples and again placed on an orbital shaker for 5min at 700rpm. Afterwards the samples 
were placed in the dark at room temperature for 10min. Then the emitted light from the 
luciferase reaction was assessed by a Luminometer. The concentrations were calculated by a ATP 
standard curve added to the measurement. 
2.7.3 Lactate 
 
Lactate Colorimetric Assay Kit II    Bio Cat 
Microplate reader      Tecan 
1 x 10
6
 purified CD8+ T cells were either left untreated or stimulated with CD3/CD8 mAbs or 
OT-I tetramers. After stimulation and subsequent washing with PBS, cells were lysed by adding 
50µL bidestilled H2O. Afterwards 50µL reaction mix from the kit containing assay buffer (48µL), 
substrate mix (2µL) and enzyme mix (2µL) was added to the sample and incubated for 30min at 
room temperature. Finally the samples including an appropriate standard curve were measured at 
a microplate reader at 450nm.  
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2.8. Immunoblotting  
 
2.8.1. Cell lysis 
 
Lysis buffer:      1% LM 
1% NP-40 
1 mM Na-monovanadate 
1 mM PMSF 
50 mM Tris-HCl (pH 7.4) 
10 mM NaF 
10 mM EDTA 
0.16 M NaCl 
 
After stimulation, 2x106 cells were washed once with ice-cold PBS. Cells were resuspended in 40 
μl lysis buffer and incubated for 20 min on ice. Samples were then centrifuged for 10 min at 
16,000 g, 4°C and the supernatant was transferred into a new eppendorf tube. 
2.8.2. Protein concentration measurement 
 
BSA standard (0-100 μg/ml)    Sigma 
Roti-Nanoquant     Roth 
Protein concentrations were determined by using the Bradford protein assay. According to the 
manufacturer’s protocol, a working solution was prepared by diluting the 5x Roti-Nanoquant to 
1x with dH2O. Samples were pre-diluted with dH2O. 50 μl of the prediluted samples were then 
transferred to a 96-well plate and incubated with 200 μl of 1x Roti-Nanoquant. Absorption was 
measured using an ELISA reader at 570 nm. BSA (0-100 μg/ml) was used as standard and the 
protein concentration was calculated on the basis of the derived standard curve. 
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2.8.3. SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) 
 
In SDS-PAGE, the migration of proteins is related to their molecular weight. 
10% and 12% SDS-PAGE separating gel:  4.2 ml (10%) or 3.44 ml (12%) dH2O 
2.46 ml 1.5 M Tris-HCl, pH 8.8 
3.2 ml (10%) or 3.94 ml (12%) 30% 
acrylamide/BIS 
0.1 ml 10% SDS 
0.05 ml 10% APS 
5 μl TEMED 
SDS-PAGE stacking gel:    2.4 ml dH2O 
0.5 ml 30% acrylamide/BIS 
1 ml 0.5 M Tris-HCl pH 6.8 
0.04 ml 10% SDS 
0.04 ml 10% APS 
0.004 ml TEMED 
SDS-PAGE running buffer (1x):   25 mM Tris, 
250 mM glycine, 
0.1% SDS 
5x reducing loading buffer :    50% glycerol 
330 mM Tris, pH 6.8 
10% SDS 
0.01% bromphenolblue 
10% 2-mercaptoethanol 
Marker:      pageruler prestained protein ladder  
Cell lysates and 5x sample buffer were mixed and boiled at 95°C for 8 min. The samples were 
then loaded and resolved on a 10% or 12% SDS-PAGE gel. For each lane, 40 μg of total protein 
were loaded. Electrophoresis was conducted with Bio-Rad Protein system. Gels were run at 120 
V for 90 min. 
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2.8.4. Western blotting analysis and immunoblotting 
 
Protein transfer buffer (1x):     39 mM glycine 
48 mM Tris 
0.037% SDS 
20% methanol 
TBS 0.01M Tris 
0.15M NaCl 
Blocking buffer:      5% milk powder in TBS 
Washing buffer:      0.02% Tween 20 in TBS 
Ponceau S solution:      0.1% Ponceau S in 5% acetic acid 
 
The proteins seperated by gel electrophoresis were then transferred to a nitrocellulose membrane, 
where they were detected using antibodies specific to the target proteins. In some experiments, 
equal loading was controlled by incubation of the membrane with Ponceau S solution for 2 min. 
The staining was removed by washing with TBS. Blocking of the membrane was performed using 
blocking buffer for 30 min to prevent unspecific binding to the membrane. Subsequently, 
membranes were probed with a primary antibody overnight 4°C. After washing 3 times with 
washing buffer, the membrane was incubated with the appropriate peroxidase-conjugated 
secondary antibody for 1 h at RT. The membrane was further washed 3 times with washing 
buffer and the bound antibodies were then visualized using an ECL (Enhanced 
Chemiluminescence) detection system according to the manufacturer’s instructions. 
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3. Results  
 
3.1. Peptide-stimulation induces metabolic reprogramming in T cells 
 
Stimulation of T cells leads to a change from a quiescent resting state into an activated state, 
which is characterized by an extensive cell growth, proliferation, and the production of effector 
proteins, such as cytokines. In the resting state, T lymphocytes maintain their basal energy 
demands primarily through a mixed usage of glucose and glutamine (Brand 1985; 
Frauwirth,Thompson 2004). However, to meet the increased energy demands following 
activation, glucose metabolism increases as a source of energy and providing precursor molecules 
for cellular biosynthesis (Frauwirth,Thompson 2004). It was previously shown that different 
stimuli lead to either proliferation or apoptosis of thymocytes (Daniels et al. 2006) and mature T 
cells (Wang et al. 2008). However, it is poorly understood how triggering of the same receptor 
with ligands of different affinity can induce such different outcomes. 
Since it is known that thymocytes which cannot fulfill their energy demands undergo apoptosis 
we hypothesized that changes in the metabolic profiles in activated T cells might contribute to 
cell fate specification. Therefore we stimulated purified OT-I T cells either with soluble 
biotinylated CD3 and CD8 monoclonal antibodies or incubated them with biotinylated H-2Kb 
molecules loaded with the SIINFEKL peptide derived from ovalbumin (OVA) (Wang et al. 
2008). Stimulated T cells were then cross-linked and further assessed for different metabolic 
parameters.  
3.1.1. Changes in intracellular ATP concentrations following T cell stimulation 
 
To determine metabolic changes upon stimulation using the two stimuli described above, we first 
assessed whether the concentration of ATP changes by measuring the level of intracellular ATP. 
In Figure 3.1. it is shown that within 4 hours of stimulation with soluble antibodies there is a 
strong decrease in intracellular ATP concentrations. In contrast to this, physiological stimulation 
lead to a mild decrease in ATP within the first 30min following stimulation, but remained 
constant for the rest of the time.  
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Figure 3.1. Soluble antibody stimulation leads to reduced intracellular ATP concentrations. Purified CD8+ T cells were 
treated with either soluble CD3/CD8 mAbs or OT-I tetramers (PMHC) for the indicated time periods. Cellular ATP 
production was analyzed using the ATP-Assay Kit. n=6. 
 
These data indicate that stimulation with soluble antibodies leads to a strong decrease in ATP, 
which could promote apoptosis by failing to upregulate cellular metabolic responses. 
 
3.1.2. Analyzing intermediates of glucose metabolism following T cell stimulation 
 
It has been shown before in several studies (Frauwirth et al. 2002; Frauwirth,Thompson 2004) 
that stimulation of CD4+ T cells leads to increased glycolytic rates to maintain the metabolic 
demands of proliferating cells. Therefore we analyzed our OT-I T cells for metabolic 
intermediates of glycolysis to see whether this upregulation can be observed also in CD8+ T cells 
and furthermore compare the changes for the two different stimuli. To measure 20 different 
intermediates of glycolysis and TCA cycle, the lysates of stimulated T cells were separated by 
high-performance anion exchange chromatography and further identified by mass spectroscopy 
(MS)(Ritter et al. 2008).  
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Figure 3.2. Stimulation with OT-I tetramers leads to upregulation of glycolytic metabolites. Purified CD8+ T cells were 
treated with either soluble CD3/CD8 mAbs or OT-I tetramers (PMHC) for the indicated time periods. Concentrations 
of glycolytic metabolites Fructose-1.6-bisphosphate (A), 3-phosphoglycerate (B), Phosphoenolpyruvate (C) and 
Pyruvate (D) where measured by MS coupled high-performance anion-exchange chromatography; n=5. 
 
For the intermediates of glycolysis we observed a strong increase of fructose-1.6-bisphosphate 
(F-1,6-bp) and 3-phosphoglycerate (3-PG) 2-4 h upon tetramer stimulation, which could not be 
observed upon antibody stimulation (Figure 3.2). Furthermore the concentration of 
phosphoenolpyruvate (Pep) was not significantly increased upon both stimuli. However, pyruvate 
the “end product” of glycolysis shows a different kinetic, in the first hours following tetramer 
stimulation there was no significant increase, but at later time points we could observe an 
increase in pyruvate concentrations. In comparison, antibody stimulation had no impact on 
pyruvate concentrations. 
In Figure 3.3, we analyzed further metabolites of the TCA cycle. Here, we observed a trend 
towards increased ketoglutarate, malate, and fumarate upon tetramer stimulation. However this 
increase was not statistically significant. In contrast to tetramer stimulation, changes in glycolysis 
and the TCA cycle were not observed after antibody stimulation. 
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Figure 3.3. TCA cycle metabolites showed no significant changes upon stimulation. Purified CD8+ T cells were treated 
with either soluble CD3/CD8 mAbs or OT-I tetramers (PMHC) for the indicated time periods. Concentrations of 
intermediates of citric acid cycle α-ketoglutarate (A), fumarate (B) and malate (C) where measured by MS coupled 
high-performance anion-exchange chromatography; n=5. 
 
Furthermore we assessed also ATP by metabolite analysis to confirm and expand the observed 
data for intracellular ATP concentrations and get a more detailed view about cellular energy 
homeostasis by additionally measuring ADP and AMP (Figure 3.4.A). Decreasing ATP 
concentrations measured upon soluble antibody stimulation were correlating to the experiment 
shown in Figure 3.1 and this trend was observed for up to 8 hours. In contrast, tetramer 
stimulation showed no decrease in ATP during the first 2 hours, afterwards it also decreases for 
up to 8 hours after stimulation. These observed effects are reflected by the inverse concentration 
behavior of ADP and AMP concentrations (Figure 3.4.B and C). Upon soluble antibody 
treatment these measurements revealed that the initial decrease in ATP lead to a strong increase 
in AMP, whereas ADP remained unaffected. Tetramer stimulation showed a relative stable ADP 
and AMP concentrations within 4 hours of the experiment. After 6h and 8h the concentrations 
for ADP dramatically increased. 
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Figure 3.4. Changes in ATP with the different stimuli. Purified CD8+ T cells were treated with either soluble 
CD3/CD8 mAbs or OT-I tetramers (PMHC) for the indicated time periods. Concentrations of ATP (A), ADP (B) and 
AMP (C) where measured by MS coupled high-performance anion-exchange chromatography; n=5. 
 
Further investigation of GTP, GDP, and GMP revealed that the effect of both stimuli did not 
alter significantly the changes in their concentrations. For GTP could observe a decrease after 6h 
to 8h (Figure3.5.A). Furthermore GDP concentrations increased at these time points (Figure 
3.5.B). GMP showed a small peak after 4 hours followed by a rapid decrease in intracellular 
concentrations Figure 3.5.C).  
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Figure 3.5. Changes in GTP concentration. Purified CD8+ T cells were treated with either soluble CD3/CD8 mAbs or 
OT-I tetramers (PMHC) for the indicated time periods. Concentrations of GTP (A), GDP (B) and GMP (C) where 
measured by MS coupled high-performance anion-exchange chromatography; n=5. 
 
3.1.3. Elevated glycolysis leads to increased lactate production upon tetramer 
stimulation 
 
The observed increase in glycolysis without significant changes in the TCA cycle lead us to 
hypothesize that pyruvate produced by glycolysis is converted into lactate (i.e. aerobic glycolysis). 
It was also shown previously that human CD4+ T cells produce lactate following CD3/CD28 
stimulation. To test our hypothesis, we directly measured lactate production (Figure 3.6.).  
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Figure 3.6. Tetramer stimulation leads to lactate production which peaks at 48h and decreased again. Purified CD8+ T 
cells were treated with either soluble CD3/CD8 mAbs or OT-I tetramers (PMHC) for the short term stimulation up to 
4h (A) and OT-I tetramers or Q4H7 tetramers for the long term stimulation (B) lactate concentrations were assessed at 
indicated time points; n=7. 
We observed a 3-fold increase in lactate production within the first 4 hours following tetramer 
stimulation, whereas there was no lactate production after antibody stimulation. When we 
analyzed later timepoints, we found that lactate production occurs at a high rate during the first 
48 hours following stimulation. At later timepoints we observed a decrease in lactate production. 
Since T cells die within 24h upon antibody stimulation, it was not feasible to measure for longer 
stimulations. Therefore we used the low affinity peptide Q4H7 as a “negative” control, as it was 
shown previously that Q4H7 is a low affinity peptide which induces survival, but not T cell 
proliferation (Mallaun et al. 2008). 
 
3.1.4. Metabolic inhibition leads to abrogated T cell proliferation 
 
In the next step we examined the role of lactate production for T cell proliferation. The addition 
of oxamate, a lactate dehydrogenase inhibitor, lead to decreased proliferation and decreased 
intracellular lactate concentrations (Figure 3.7 A and B). Nevertheless, inhibiting the ATP 
production with rotenone lead to a complete block in proliferation, but did not effect lactate 
production. This inhibition is rather indirect because rotenone blocks complex I of the electron 
transport chain, disrupting the proton gradient at the mitochondrial membrane, which in the end 
abolishes the ATP synthase reaction. 
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Figure 3.7. Inhibition of lactate production leads to reduced T cell proliferation. Purified CD8+ T cells were stimulated 
for 72h with OT-I tetramers in presence of the inhibitors rotenone and oxamate, proliferation was assessed by CFSE 
staining (A) and lactate production was measured at indicated time points. 
To check that these inhibitory effects are not due to toxic effects of the inhibitors, we examined 
the induction of apoptosis and necrosis versus survival of the T cells by Annexin V/PI staining 
upon tetramer stimulation in presence or absence of the inhibitor. The observed data suggests 
that the inhibitor concentrations used had only a mild effect on T cell survival (Figure 3.8.). 
Rotenone lead to an increase in apoptotic cells from 22% to 26% whereas oxamate treatment 
increases the amount of apoptotic cells from 22% to 30%. Therefore we concluded that these 
findings were due to the proposed effect of the inhibitors and not due to high toxicity. 
 
Figure 3.8. No severe toxic effects were observed upon application of the inhibitors. Purified CD8+ T cells were 
stimulated for 24h with OT-I tetramers in presence of the inhibitors rotenone and oxamate, apoptosis was assessed by 
Annexin V/PI staining 
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3.2. Regulation of T cell metabolic reprogramming following tetramer 
stimulation 
 
In order to shed more light onto the metabolic changes occuring during T cell proliferation, we 
investigated the activation of known metabolic regulators like AMPK and the 
PI3K/AKT/mTOR pathway. We were particularl interested to further examine the regulation of 
metabolic reprogramming in T cells. Since only tetramer stimulation shows changes in metabolic 
parameters leading to T cell proliferation, we therfore focussed our work on the events following 
tetramer stimulation.  
3.2.1. AMPK 
First we analyzed the activation of the metabolic regulator AMPK, which becomes 
phosphorylated by LKB1 if the AMP:ATP ratio is increased. Here we show that AMPK is 
activated immediately by both stimuli (Figure 3.9). At later time points, antibody-stimulated T 
cells continue to show a sustained activation of AMPK, whereas tetramer-stimulated cells do not.  
 
 
Figure 3.9. Soluble antibody stimulation leads to sustained AMPK activation. Purified CD8+ T cells were stimulated 
for indicated timepoints with either CD3/CD8 soluble antibodies or OT-I tetramers, whole cell lysates were 
immunoblotted with p-AMPK, total AMPK and p-ERK antibody, ß-actin served as loading control. 
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3.2.1.1. AKT and mTOR  
 
Since it is known that the PI3K/AKT/mTOR pathway is required for metabolic regulation of 
cellular metabolism, we investigated the contribution of AKT and mTOR. Therefore we 
inhibited mTOR by using rapamycin. Rapamycin binds to the protein FK-binding protein 12 
(FKbp12), the resulting FKbp12-rapamycin complex is then binding to the TSC1 protein of the 
mTOR complex and therefore inhibiting it´s activity (Loewith et al. 2002). Inhibition of AKT 
was mainly done using the AKT inibitor, AKT VIII which binds to the ph-domain of AKT and 
therefore inhibits the recruitment of AKT to the cell membrane. Inhibition of mTOR with 
rapamycin showed no effect on lactate production, while the inhibition of AKT completely 
abrogated lactate production (Figure 3.10.). The phosphorylation of S6K, which is downstream 
of AKT and mTOR was used as a positive control to ensure inhibitor function. In Figure 3.11. 
the observed phosphorylation of S6K was strongly reduced in presence of both inhibitors. 
 
Figure 3.10. Inhibition of AKT leads to reduced lactate production. Purified CD8+ T cells were left untreated or 
stimulated for indicated timepoints with OT-I tetramers in the presence or absence of the inhibitors AKTVIII and 
Rapamycin (RAPA), cells were analyzed for intracellular lactate concentrations.  
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Figure 3.11. Succesful inhibition of AKT and mTOR leads to abrogated phosphorylation of S6K. Purified CD8+ T cells 
were left untreated or stimulated for indicated timepoints with OT-I tetramers in the presence of rapamycin (A) or 
AKTVIII (B), whole cell lysates were immunoblotted with p-S6K and p-ERK antibody, ß-actin served as loading 
control. 
 
3.2.1.2. Regulation of metabolic enzymes by activation of AKT 
 
Additionaly, it is shown for the first time that activation of AKT upregulates the expression of 
LDH, the enzyme which converts pyruvate to lactate. In Figure 3.12. this observation was 
confirmed using 3 specific functionally distinct AKT inhibitors, which lead to a marked reduction 
in LDH expression. This was accompanied by a strong and significant reduction in lactate 
production after 4h and 24h following stimulation in the presence of AKT inibitors. 
 
Figure 3.12. Inhibition of AKT with three different inhibitors leads to reduced upregulation of LDH. Purified CD8+ T 
cells were stimulated for indicated timepoints with OT-I tetramers in the presence of 3 specific AKT inhibitors, whole 
cell lysates were immunoblotted with total LDH and ß-actin as loading control (A) or cells were analyzed for 
intracellular lactate concentrations; n=3. 
Furthermore we assessed the expression of hexokinase and phosphofructokinase (Figure 3.13.). 
Both enzymes catalyze reactions of the glycolysis and play a key role in enzymatically regulating 
this pathway. There was only mild increase in hexokinase expression observed upon 24 and 48h 
following stimulation; however phosphofructokinase showed a marked upregulation after 24h 
and 48h. Both expression patterns were not influenced by inhibition of AKT. 
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Figure 3.13. Inhibition of AKT has no effect on upregulation of hexokinase and phosphofructokinase. Purified CD8+ T 
cells were stimulated for indicated time points with OT-I tetramers in the presence of specific AKT inhibitor, whole 
cell lysates were immunoblotted with total hexokinase, total pfk1 and pERK, ß-actin served as loading control. 
 
3.2.1.3. Hif1α is not a downstream target of AKT 
 
Since mTOR is a downstream target of AKT and AKT-inhibition showed a strong impact on 
lactate metabolism in T cells, whereas mTOR did not, we searched for a direct target of AKT 
bypassing mTOR. Hif1α is a transcription factor which is known to regulate cellular metabolism 
(Cramer et al. 2003). Although it was previously described that Hif1α is mainly activated under 
hypoxic conditions (Shi et al. 2011), we hypothesized that AKT regulating Hif1α also under 
normoxic conditions. In Figure 3.14 Hif1α stabilization following T cell stimulation was 
examined. There is no difference observed between soluble stimulation and tetramer stimulation 
in the presence or absence of the AKT inhibitor.  
 
Figure 3.14. No stabilization of Hif1α was observed upon T cell stimulation under normoxic conditions. Purified CD8+ 
T cells were stimulated for indicated time points with soluble antibodies or OT-I tetramers in the presence of specific 
AKT inhibitor, whole cell lysates were immunoblotted with total Hif1α and pERK, ß-actin served as loading control. 
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3.2.1.4. Impact of AKT activation on expression of glucose transporter 1 (GLUT1) 
and glucose uptake 
 
It was described previously for human CD4+ T cells that stimulation leads to an upregulation of 
glucose transporter 1 (GLUT1). This observation could be confirmed by flow cytometry 
measurements of GLUT1-expression (Figure 3.15.). Additionally, no significant impact of AKT 
inhibition on GLUT1 expression was observed. 
 
Figure 3.15. Upregulation of GLUT1 is not affected by AKT inhibition. Purified CD8+ T cells were stimulated for 
indicated time points with OT-I tetramers in the presence of specific AKT inhibitor, cells were analyzed by flow 
cytometry for GLUT1 expression. 
Furthermore we analyzed the subsequent uptake of glucose by activated T cells. Here we 
observed an increased glucose uptake upon tetramer stimulation (Figure 3.16.), which reflects the 
upregulation of GLUT1 described above. This correlation was also observed in presence of the 
inhibitor application, which had no influence on glucose uptake. 
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Figure 3.16. Upregulated glucose uptake upon tetramer stimulation is not altered by AKT inhibition. Purified CD8+ T 
cells were stimulated for 24h with OT-I tetramers in the presence or absence of specific AKT inhibitor or glucose 
transport inhibitor apigenin as negative control, cells were analyzed by flow cytometry for glucose uptake. 
 
3.2.2. Switching off lactate production 
 
In Figure 3.6B the lactate concentrations increased for 48 hours and then rapidly decreased. 
Therefore we hypothesized that in addition to a metabolic switch that turns on lactate 
production; there must also be a switch for shutting off this process.  
 
3.2.2.1. No feedback inhibition of lactate 
 
In our experimental setup, the activated T cells secrete lactate into the culture medium. Since in 
vivo this produced lactate is transported away, we hypothesized that the accumulating lactate 
might lead to feedback inhibition of its production. Feedback inhibition is a common mechanism 
to regulate metabolic processes and it is characterized by enzyme inhibition mediated by its 
product. To test this hypothesis, we added different concentrations of lactate to the stimulation 
reactions and assessed the intracellular lactate concentration after 4h, 24h, and 48h.  
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Figure 3.17. No feedback inhibition of lactate on lactate production. Purified CD8+ T cells were stimulated for 24h 
with OT-I tetramers in the presence or absence of different lactate concentrations, cells were analyzed for intracellular 
lactate concentrations, n=2. 
The results shown in Figure 3.17. lead to the conclusion that there is no impact of extracellular 
lactate concentrations on intracellular lactate production up to a concentration of 100µM. 
 
3.2.2.2. IL-2 is required for maintaining upregulated glycolysis 
 
IL-2 is an autocrine growth factor which drives proliferation at later stages of T cell activation. 
Therefore, we tested the hypothesis that IL-2 might be involved in switching off lactate 
production. To test this, we applied a neutralizing IL-2 antibody to our cultures in order to 
prevent the binding of IL-2 to its receptor. To confirm that our neutralizing IL-2 antibody was 
effective and not toxic, we analyzed Stat5 phosphorylation 24h after stimulation (Figure 3.18.A) 
as well as apoptosis (Figure 3.18.B).  
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Figure 3.18 Addition of IL-2 neutralizing antibody leads to reduced pSTAT5 phosphorylation and showed no severe 
toxic effects. Purified CD8+ T cells were stimulated for 24h with OT-I tetramers in the presence or absence of aIL-2 
antibody, cells were analyzed for pSTAT5 by intracellular flow cytometry staining (A) and apoptosis induction by 
AnnexinV/PI staining (B), n=2 
Surpisingly, when the neutralizing IL-2 antibody was added to the culture, we observed a 
decreased lactate production (Figure 3.19.) after 24h stimulation which decreased further after 
48h and 72h. Moreover, the addition of exogenous IL-2 to the stimulated cells fostered the 
production of lactate, leading to higher concentrations of lactate compared to normal tetramer 
stimualtion. This led us to the conclusion that IL-2 is needed to maintain lactate production and 
does not act as the 'OFF switch for lactate production.  
 
 
Figure 3.19 IL-2 is required to maintain lactate production. Purified CD8+ T cells were stimulated for 24h with OT-I 
tetramers in the presence of exogenous IL-2 or aIL-2 antibody, cells were analyzed for intracellular lactate 
concentrations, n=3. 
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3.2.2.3. Upregulation CTLA4 inhibits IL-2 production and subsequently shuts off 
the production of lactate 
 
Since CTLA4 is known to be a negative regulator of T cell proliferation, we investigated the 
impact on CTLA4 on T cell metabolism. Therefore we analyzed the lactate production CTLA4-
deficient OT-I T cells and compared them to wild-type OT-I T cells. Surprisingly the CTLA4-/- T 
cells showed a different kinetic of lactate production compared to normal OT-I T cells. After 48h 
of stimulation the produced lactate did not decrease, but rather continued to increase 
(Figure 3.20). 
 
Figure 3.20. CTLA4-/--OT-I T cells showed no decrease in lactate production.  Purified CD8+ T cells from CTLA-/- or 
CTL4+/+ mice were stimulated with OT-I tetramers for indicated time points, cells were analyzed for intracellular 
lactate concentrations, n=3. 
The further analysis of IL-2 production in CTLA4-/- T cells revealed that also IL-2 production is 
not decreasing after 48h of stimulation as was observed for wild-type OT-I T cells (Figure 3.21). 
Taken together, the similar behavior of IL-2 and lactate production combined with the 
observations made by adding exogenous IL-2 or neutralizing IL-2 (i.e. aIL-2 antibodies) lead us 
to the conclusion that the upregulation of CTLA4 leads to a decrease in IL-2 production, which 
subsequently results in a decreased lactate production. 
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Figure 3.21. Upregulation of CTLA4 leads to decrease of IL-2 production. Purified CD8+ T cells from CTLA-/- or 
CTL4+/+ OT-I mice were stimulated with OT-I tetramers for indicated time points, cells were analyzed for intracellular 
IL-2 concentrations by ELISA, n=3. 
 
3.3. Comparing stimulation conditions for mouse and human T cells 
 
It was previously shown that primary human T cells respond to the stimulation with CD3/CD28 
coupled beads by upregulating both glycolysis and lactate production (Frauwirth et al. 2002). We 
confirmed this observation by stimulating primary human T cells with beads coupled with CD3 
alone or in combination with CD28 (Figure 3.22.A). We found that there is a strong upregulation 
of lactate production upon CD3/CD28 stimulation, whereas the increase in lactate production 
upon CD3 stimulation alone appeared to be much weaker. When we applied these stimulation 
conditions to CD8+ OT-I T cells (Figure 3.22.B) both bead coupled antibodies as well as 
tetramers showed the same induction of lactate production. While the addition of co-stimulatory 
CD28 to the CD3 stimulation in human T cells leads to a significant increase in lactate 
production, there was only a minor increase observed in mouse T cells.  
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Figure 3.21 Purified human CD8+ T cells were stimulated CD3/CD28 bead coupled Abs (A) or mouse CD8+ T cells  
stimulated with OT-I tetramers (B) were analyzed for lactate production, n=3. 
To control whether CD28 stimulation was successful, we analyzed JNK phosphorylation as we 
had previously shown that CD28 stimulation alone induces the activation of JNK (REF) 
(Figure 3.22.). From this we conclude that the addition of CD28 to the tetramer stimulation had 
no impact on lactate production. 
 
Figure 3.22. Comparable JNK phosphorylation upon stimulation with OT-I tetramers and CD28.  Purified CD8+ T 
cells were stimulated for 3´ and 60´ with OT-I tetramers, CD28 and both together, whole cell lysates were 
immunoblotted with pJNK, ß-actin served as loading control, n=2. 
 
In summary, we found that tetramer induced activation result in an increase in key glycolytic 
metabolites, whereas the TCA cycle remains unaffected. The upregulation of glycolysis led to a 
strong lactate production, which is dependent upon AKT/PKB, but not mTOR. The increased 
lactate production results from the upregulation of lactate dehydrogenase, which we found to be 
dependent on IL-2 and to be required for proliferation. Additionally, we observed an 
upregulation of Glucose-transporter 1 (GLUT1) as well as glucose uptake upon stimulation, 
which were not influenced by AKT inhibition. Furthermore knocking out CTL4, a negative 
regulator of T cell proliferation, led to a sustained lactate production, which correlates with a 
sustained IL-2 production. Thus we conclude that the upregulation of CTL4 in the later stage of 
T cell activation shuts off lactate production by down regulating the production of IL-2.
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4. Discussion 
 
4.1. Effect of different stimuli on T cell metabolism  
 
Triggering the T cell receptor by pathogens in vivo leads to an activation of a specific network of 
signaling cascades. These signaling events are crucial for proliferation and differentiation leading 
to a functional immune response. To elucidate the complex intracellular networks soluble 
polyclonal stimuli such as agonistic antibodies against the TCR/CD3 complex (i.e UCHT1, 
OKT3), the co-receptors and/or the co-stimulatory molecules (i.e. CD28) were used for many 
years. However recent studies have shown that these in vitro stimuli are not able to mimic 
physiological conditions leading to a productive T cell response (Daniels et al. 2006; Wang et al. 
2008; Arndt et al. 2013). It was described previously for OT-I mouse T cells that stimulation with 
soluble antibodies leads to strong phosphorylation of the T cell signaling network (i.e. ZAP70, 
AKT and ERK) which results in apoptosis (Brand et al. 1984; Wang et al. 2008). On the contrary 
more physiological stimuli like OT-I tetramers for mouse T cells or antibodies coupled to 
microbeads for human T cells showed sustained phoshorylation of signaling proteins that leads 
to proliferation and differentiation of T cells reflecting the in vivo stimulations. The reason why 
these stimuli have different outcomes on the T cell fate still remains unclear. Our hypothesis to 
explain these opposite cellular responses was that the depletion of the intracellular ATP stores 
following antibody stimulation could be responsible for the induction of apoptosis. It was 
previously shown that intracellular ATP levels can be used as a marker for cell viability in tumor 
cell lines meaning that if intracellular ATP concentrations fall below a certain limit, apoptosis is 
induced (Garland 1997; Izyumov et al. 2004). On the other hand, several studies showed that 
apoptotic processes require ATP to transfer apoptotic signals into the nucleus as well as for 
chromatin condensation and nuclear fragmentation (Tsujimoto 1997; Yasuhara et al. 1997; Kass 
et al. 1996). We observed a rapid consumption of ATP upon antibody stimulation, whereas ATP 
levels remain constant after tetramer stimulation. The question is whether the drop in ATP levels 
are the cause or a consequence of the resulting apoptosis. First consider that the changes in ATP 
levels were observed already within the first hour of stimulation. From this one is led to assume 
that the dramatic phosphorylation which occurs upon antibody stimulation leads to a high 
consumption of ATP (Leist et al. 1997). This in turn results in the induction of apoptosis, which 
further reinforces the reduction in ATP levels. Therefore these results suggest that following 
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tetramer stimulation, T cells switch on metabolic programs to generate ATP in order to 
counterbalance their ATP consumption. 
Therefore, we next investigated the activation of AMPK, as this is the major energy sensor in 
cells and its activation is closely linked to intracellular ATP levels. We observed an initial 
activation of AMPK upon both tetramer and antibody stimulation. This initial activation was 
previously reported to be induced by the activation of CAMKK2 upon TCR triggering (Tamás et 
al. 2006). Since AMPK is further activated by a high AMP:ATP ratio, the decreased ATP levels 
observed upon antibody stimulation forces AMPK to remain active. In contrast, upon tetramer 
stimulation, T cells maintain high levels of ATP, thus inactivating AMPK. This led us to the 
conclusion that tetramer stimulation induces additional changes in the metabolic profiles, since 
the initial activation of AMPK is not sufficient to shift T cell metabolism towards glycolysis, 
which is needed to maintain proliferation.  
 
4.2. Metabolic changes upon tetramer stimulation 
 
Several previous studies analysed the upregulation of glycolysis by monitoring glucose 
consumption from the media, direct glucose uptake by the cell, or the upregulation of GLUT1 
(Frauwirth et al. 2002; Macintyre et al. 2011; Bauer et al. 2004). We used a new method to analyze 
25 metabolites and nucleotides from both glycolysis and the TCA cycle in order to further 
investigate the metabolic shift. In our experiments with tetramer stimulation, we clearly observed 
a significant increase in glycolytic metabolites compared to either the antibody stimulated or 
unstimulated cells. Taking a closer look at the glycolytic reactions, it is thought that there exist 
three rate-limiting steps at positions in the pathway where large free energy differences arise: 
hexokinase, phosphofructokinase, and pyruvate kinase (Rose,Warms 1966; Rapoport et al. 1976; 
Hue,Rider 1987). Surprisingly no increase in the concentrations of substrates for these reactions 
were found in our analysis. On the contrary, increased levels of fructose-1,6-bisphosphate and 3-
phosphoglycerate, the respective substrates for the phosphofructokinase and glycerinaldehyde-3-
phosphatedehydrogenase reactions where observed. In the recent study by Shestov et al. 
GAPDH was identified as a limiting step by computational modeling of glycolysis and an 
integrated metabolic control analysis (Shestov et al. 2014). They propose that GAPDH is the 
bottleneck in this pathway due to its unique placement where it can be regulated by ATP, 
NAD+, and the levels of glucose-derived intermediates that affects the thermodynamics of 
glycolysis. Furthermore in this study the authors explained that high concentrations of fructose-
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1,6-bisphosphate are allosterically activating pyruvate kinase causing a depletion in the 
metabolites downstream of the GAPDH. This amplified the role of GAPDH as the most rate-
determining step in the pathway since increased activity through GAPDH will then serve to 
create a balance along the pathway. This observations might help in understanding the results of 
our metabolite analysis in T cells, as they confirm that the overall glycolytic rate is increased. In 
addition after tetramer stimulation, T cells produce high amounts of lactate, which is an 
indication for increased aerobic glycolysis. The fact that lactate production is essential for T cell 
proliferation was confirmed by the observation that the addition of oxamate, a lactate 
dehydrogenase inhibitor, leads to decreased proliferation. We also observed small changes in the 
metabolites of the TCA cycle, however these were not statistically significant. Nevertheless, T 
cells still require the TCA cycle to maintain proliferation, as shown by inhibiting the ATP 
production with rotenone. This inhibition is rather indirect because rotenone blocks complex I of 
the electron transport chain, disrupting the proton gradient at the mitochondrial membrane, 
which in the end abolishes the ATP synthase reaction. In a recent study comparing metablic 
features of T cell subsets, the authors observed striking differences between CD8+ T cells, which 
showed more glycolytic metabolism, compare to CD4+ T cells, which show higher rates of 
mitochondrial oxidative metabolism and a greater maximal respiratory capacity (Cao et al. 2014). 
Nevertheless activation and proliferation of both cell types were similar sensitive to the addition 
of rotenone. This supports the idea that the TCA cycle is not only required for the generation of 
ATP, but is also essential to deliver substrates for biosynthetic processes like the generation of 
nucleotides, which are neede for proliferation. Furthermore it has been shown that during 
oxidative phosphorylation, reactive oxygen species are generated, which played a critical role in T 
cell activation (Sena,Chandel 2012). In summary T cells require an increased in both pathways, 
glycolysis and TCA cycle, to support rapid proliferation and inflammatory function.  
 
4.3. Shutting off increased glycolysis and lactate production. 
 
Surprisingly we observed that after 48 hours of activation, lactate production decreases. This 
observation led us to hypothesize that there is a switch in T cell metabolism to shut down aerobic 
glycolysis. IL-2 is the autocrine growth factor responsible for the switch from antigen-driven 
proliferation to cytokine-driven proliferation. Since IL-2 production occurs on a similar time 
scale, we tested the hypothesis that IL-2 might be involved in switching off lactate production. 
When we tested this hypothesis we found that IL-2 is required to maintain lactate production. 
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This observation contradicts a previous study were the authors showed that the removal of IL-2 
within the first 20h of stimulation had no effect on lactate production in primary human CD4 T 
cells (Frauwirth et al. 2002). Under normal conditions, it is known for humans that the lactate 
produced is pumped out of the cell and transported by the bloodstream to organs like the liver 
where lactate recycling takes place. Since our in vitro assays lead to an accumulation of 
extracellular lactate we tested whether feedback inhibition, a common process for regulating 
enzymatic activities, can be observed. Adding up to 100µM exogenous lactate to the cells, which 
is about the amount of lactate we measured extracellularly in vitro, had no impact on the 
intracellular lactate production, therefore we could exclude feedback inhibition as a reason for the 
decreased lactate production after 48h in our experimental system. Although we can not exclude 
feedback inhibition in vivo as concentrations in the bloodstream can reach 5mM during high 
muscular activity. Since it is known that IL-2 induces negative regulators of T cell activation like 
CTLA4, which downmodulate T cell responses to prevent an overreaction of the immune system 
(Frauwirth et al. 2002; Parry et al. 2005), we next assessed lactate production in OT-I T cells from 
CTLA4-/- mice upon stimulation. Interestingly the decrease in lactate production could not be 
observed in these cells indicating that CTLA4 plays a critical role in downmodulating T cell 
metabolism. Furthermore this activity could be correlated to the IL-2 production in these cells. 
Under normal conditions the expression of IL-2 ultimately leads to the upregulation of CTLA4 
(Alegre et al. 1996; Wang et al. 2001). This in turn leads to a downregulation of IL-2, which 
would explain the observed decrease in lactate production (Carreno et al. 2000). In a recent study, 
it was shown that the upregulation of BCL-6 represses genes encoding molecules involved in 
aerobic glycolysis that are upregulated during the effector phase of the immune response 
(Oestreich et al. 2014). A connection between the expression of CTLA4 and BCL-6 has been 
discussed recently in the generation of follicular helper T cells (Wang et al. 2015), but if it is a 
common feature in downmodulation T cell metabolism remains unclear and has to be addressed 
in further experiments. Furthermore it has been shown that a blockade of CTLA4 and PD-1 
leads to an increased tumor rejection in the B16 mouse melanoma model by increased infiltration 
of T cells into the tumor and decreased generation of regulatory T cells (Curran et al. 2010).  
In summary we showed a strong correlation of IL-2 and CTLA4 for mediating the switching of 
upregulated T cell metabolism. However it has to be further investigated if the downregulation of 
lactate production is a direct effect of CTLA4 upregulation and what might be the molecular 
mechaism behind this observation. 
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4.4. Regulation of T cell metabolism 
 
Since it is known that the PI3K/AKT/mTOR pathway is required for metabolism, we analyzed 
the contribution of AKT and mTOR, as both are nvolved in signaling processes known to 
regulate cellular metabolism (ANDRES et al. 1955; Rathmell et al. 2003). Inhibition of mTOR 
with rapamycin showed no effect on lactate production, while the inhibition of AKT completely 
abrogated lactate production. Additionally, we show for the first time that activation of AKT 
upregulates the expression of lactate-dehydrogenase, the enzyme which converts pyruvate to 
lactate. This observation was confirmed using functionally distinct AKT inhibitors, all of which 
abrogated the expression of LDH. 
Moreover, we observed an increase in GLUT1 expression and glucose uptake upon tetramer 
stimulation, which was also been previously described in primary human T cells (Rathmell et al. 
2003; Frauwirth et al. 2002). In contrast to these previous studies, the upregulation of GLUT1 
and glucose uptake in OT-I CD8+ T cells was not AKT-dependent. These contradictory results 
were also described in a recent study by Macintyre and coworkers (Macintyre et al. 2011), who 
showed that inhibition of AKT had no effect on glucose uptake after stimulation of P14 TCR tg 
T cells with gp33 peptide. Thus, we confirm the results of Macintyre showing that AKT has no 
impact on the uptake of glucose. However, we additionally show that AKT is required for the 
upregulation of lactate dehydrogenase expression. Therefore, we suggest that GLUT1 
upregulation and glucose uptake are regulated in an AKT-independent manner, whereas lactate 
production strongly requires the activation of AKT. It was shown that phosphoinositol-
dependent protein kinase 1 (PDK1), an upstream activator of AKT, is responsible for the 
upregulation of glucose uptake independent of the PI3K/AKT pathway (Macintyre et al. 2011). 
Since the role of PDK1 was assessed in T cell blasts in the presence of high IL-2 concentrations, 
there is a strong temporal separation from our system. We clearly observe the upregulation of 
LDH in parallel to the activation of AKT within 48h upon stimulation. This leads to the 
hypothesis that AKT activation upon stimulation induces an upregulation of LDH, whereas IL-2 
production induces an AKT independent upregulation of glucose uptake via PDK1.  
Surprisingly the inhibition of mTOR by rapamycin had no effect on lactate production, since it 
was described that mTOR is one of the crucial players in nutrient sensing in mammalian cells. 
Previous studies revealed an important role of mTOR in the regulation of differentiation  into 
CD4+ T cell subsets like Th1, Th2 and Th17 cells (Michalek et al. 2011; Shi et al. 2011). 
Furthermore we observed no activation of HIF1α in our study which was proposed to be a link 
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between mTOR and upregulation of glycolytic enzymes (Shi et al. 2011). Therefore we could 
conclude that mTOR activation is not required for upregulation of glycolysis in CD8+ T cells. 
Since it was also shown that inhibition of mTOR drives memory T cell formation (Pearce et al. 
2009), the addition of rapamycin is a powerful target in modulating CD4+ T cell related 
autoimmune diseases like multiples sclerosis (Esposito et al. 2010) with minimal effect on CD8+ 
T cell responses. 
 
4.5. CD28 costimulation is dispensable for OT-I T cells stimulated with 
tetramers  
 
A change in metabolism and the production of lactate has also been described for primary human 
CD4+ T cells (Salmond et al. 2009). We were able to confirm these previous results showing that 
CD3 alone induced only a weak production of lactate, whereas the addition of co-stimulation via 
CD28 led to a full activation of lactate production in human T cells. When we applied these 
conditions to our CD8+ mouse model, we see a insignificant difference between the stimulation 
with CD3 alone and the co-stimulation with CD28. Additionally, we show that tetramer 
stimulation leads to a level of lactate production similar to that after stimulation with antibodies 
coupled to beads. This supports the hypothesis made by Wang et al. that stimulation of CD8+ T 
cells does not require a co-stimulatory signal in contrast to CD4+ T cells (Wang et al. 2000). 
Similar effects were shown in a study were the blockade of the CD28 pathway hat no effect on 
allograft rejection mediated by CD8+ T cells (Newell et al. 1999). 
 
4.6. Modulating metabolism 
 
We show that CD8+ T cells undergo rapid metabolic changes following activation in order to 
maintain their energetic needs for proliferation and differentiation leading to a functional 
immune response. As mentioned before CD4+ T cells were shown to perform in a similar way 
upon activation. However other T cell subsets like regulatory or memory T cells require different 
metabolic programs according to their function. It was shown for these subsets that their 
metabolism mostly relying on an increased TCA cycle (Pearce et al. 2009; Delgoffe et al. 2009). 
The induction of fatty acid oxidation feeding into the TCA cycle leads to an enhanced generation 
of memory T cells. It was shown that inhibition of mTOR substantially increased the generation 
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of memory T cells during vaccination and virus infection. In our work we identified several key 
molecules to modulate T cell metabolism. Inhibition of AKT or an upregulation of CTLA4 could 
be possible targets for preventing the overreaction and exhaustion of T cells as seen in chronic 
viral infections, like HIV or HCV. Until now some metabolic inhibitors have been shown to 
suppress T cell responses in EAE, asthma, and graft versus host disease (Dang et al. 2011; Shi et 
al. 2011; Ostroukhova et al. 2012; Gatza et al. 2011). Furthermore a recent study revealed an 
altered metabolism in CD4+ T cells from a systemic lupus erythematosus (SLE) mouse model 
(Yin et al. 2015). These T cells showed besides upregulation of glycolysis and elevated 
mitochondrial oxidative metabolism. The addition of 2-deoxyglucose to downregulate glycolytic 
levels together with metformin, which downmodulates the TCA-cycle, could reverse disease 
biomarkers. A key goal of future work will be to determine how the activation environment in 
vivo alters metabolic reprogramming in specific disease states. Recently a new molecule was 
identified called lymphocyte expansion molecule (LEM, Okoye et al. 2015), which was shown to 
promote antigen specific CD8+ T cell expansion, effector function, and memory cell generation. 
LEM was observed to regulate the protein complexes of the oxidative phosphorylation pathway 
in the inner membrane of the mitochondria thereby upregulating the generation of reactive 
oxygen species which play a crucial role in T cell proliferation. Nevertheless the whole 
mechanism how this modulation effects T cell beahviour remains unclear. This leads to the 
conclusion that changes in T cell metabolism can alter T cell expansion and differentiation 
making metabolic regulation a powerful target for treatment of a large variety of diseases like  
immune-related diseases characterized by hyperactive T cells.     
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6. Abbreviations 
 
ADP adenosine diphosphate 
AMP adenosine monophosphate 
AMPK 5' adenosine monophosphate-activated protein 
kinase 
ATP adenosine triphosphate 
BSA bovine serum albumin 
CTLA4 cytotoxic T-lymphocyte-associated protein 4 
DMSO dimethyl sulfoxide 
EDTA ethylenediaminetetraacetic acid 
ERK extracellular-signal-regulated kinase 
GDP guanosine-5'-diphosphate 
GLUTI glucose transporter 1 
GMP guanosine-5'-monophosphate 
GTP guanosine-5'-triphosphate 
HIF1α Hypoxia-inducible factor 1-alpha 
IL interleukin 
LDH lactate dehydrogenase 
LKB1 liver kinase B1 
MHC major histocompatibility complex 
mTOR mammalian/mechanistic target of rapamycin 
NADH nicotinamide adenine dinucleotide 
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NTP nucleoside triphosphate 
OXPHOS oxidative phosphorylation 
PBS phosphate buffered saline 
PDK1 3-phosphoinositide dependent protein kinase-1 
TCA-cycle tricarboxylic acid cycle 
TCR T cell receptor 
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